We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $13.19, moving +1.38% from the previous trading session. This change lagged the S&P 500's 2.28% gain on the day. Elsewhere, the Dow gained 2.24%, while the tech-heavy Nasdaq added 1.72%.
Heading into today, shares of the hospital operator had lost 54.76% over the past month, lagging the Medical sector's loss of 8.8% and the S&P 500's loss of 16.08% in that time.
THC will be looking to display strength as it nears its next earnings release. In that report, analysts expect THC to post earnings of $0.51 per share. This would mark a year-over-year decline of 5.56%. Our most recent consensus estimate is calling for quarterly revenue of $4.72 billion, up 3.95% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.83 per share and revenue of $19.23 billion. These totals would mark changes of +5.6% and +4.09%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for THC. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 3.71% lower. THC is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, THC currently has a Forward P/E ratio of 4.6. This represents a discount compared to its industry's average Forward P/E of 7.31.
Investors should also note that THC has a PEG ratio of 0.53 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Hospital stocks are, on average, holding a PEG ratio of 0.65 based on yesterday's closing prices.
The Medical - Hospital industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 101, which puts it in the top 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Gains But Lags Market: What You Should Know
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $13.19, moving +1.38% from the previous trading session. This change lagged the S&P 500's 2.28% gain on the day. Elsewhere, the Dow gained 2.24%, while the tech-heavy Nasdaq added 1.72%.
Heading into today, shares of the hospital operator had lost 54.76% over the past month, lagging the Medical sector's loss of 8.8% and the S&P 500's loss of 16.08% in that time.
THC will be looking to display strength as it nears its next earnings release. In that report, analysts expect THC to post earnings of $0.51 per share. This would mark a year-over-year decline of 5.56%. Our most recent consensus estimate is calling for quarterly revenue of $4.72 billion, up 3.95% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.83 per share and revenue of $19.23 billion. These totals would mark changes of +5.6% and +4.09%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for THC. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 3.71% lower. THC is currently sporting a Zacks Rank of #3 (Hold).
Digging into valuation, THC currently has a Forward P/E ratio of 4.6. This represents a discount compared to its industry's average Forward P/E of 7.31.
Investors should also note that THC has a PEG ratio of 0.53 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Hospital stocks are, on average, holding a PEG ratio of 0.65 based on yesterday's closing prices.
The Medical - Hospital industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 101, which puts it in the top 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.